Advertisement
UK markets close in 5 hours 36 minutes
  • FTSE 100

    8,090.45
    +50.07 (+0.62%)
     
  • FTSE 250

    19,725.82
    +6.45 (+0.03%)
     
  • AIM

    755.19
    +0.50 (+0.07%)
     
  • GBP/EUR

    1.1668
    +0.0023 (+0.20%)
     
  • GBP/USD

    1.2515
    +0.0053 (+0.43%)
     
  • Bitcoin GBP

    51,046.65
    -1,956.58 (-3.69%)
     
  • CMC Crypto 200

    1,363.46
    -19.11 (-1.38%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.63
    -0.18 (-0.22%)
     
  • GOLD FUTURES

    2,338.60
    +0.20 (+0.01%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,983.37
    -105.33 (-0.58%)
     
  • CAC 40

    8,045.24
    -46.62 (-0.58%)
     

2 Stocks Down 72% or More to Buy in 2023 and Hold for 10 Years

2 Stocks Down 72% or More to Buy in 2023 and Hold for 10 Years

For those who need inspiration, let's consider two stocks that have been trashed this year but still boast solid, long-term prospects: Tandem Diabetes Care (NASDAQ: TNDM) and Roku (NASDAQ: ROKU). In the next decade, Tandem Diabetes Care can count on its disruptive innovations and the increase in the number of diabetes patients to deliver outsize returns. The company's t:slim X2 insulin pump is much easier on people with diabetes than multiple daily injections (MDIs) and Tandem's product provides features that most don't offer, including continuous glucose monitoring integration to automate the insulin delivery system completely.